Anagrelide and Mutational Status in Essential Thrombocythemia

被引：0
|
作者：
Alessandra Iurlo
Daniele Cattaneo
Nicola Orofino
Cristina Bucelli
Sonia Fabris
Agostino Cortelezzi
机构：
[1] IRCCS Ca’ Granda–Maggiore Policlinico Hospital Foundation and University of Milan,Oncohematology Division
[2] IRCCS Ca’ Granda–Maggiore Policlinico Hospital Foundation,Oncohematology Unit of the Elderly
来源：
BioDrugs | 2016年 / 30卷
关键词：
Mutational Status; Hydroxyurea; Essential Thrombocythemia; JAK2V617F Mutation; Platelet Response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：219 / 223
页数：4
相关论文
共 50 条
  • [1] Anagrelide and Mutational Status in Essential Thrombocythemia
    Iurlo, Alessandra
    Cattaneo, Daniele
    Orofino, Nicola
    Bucelli, Cristina
    Fabris, Sonia
    Cortelezzi, Agostino
    BIODRUGS, 2016, 30 (03) : 219 - 223
  • [2] Anagrelide for essential thrombocythemia
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1997, 39 (1016): : 120 - 120
  • [3] Treatment of essential thrombocythemia with anagrelide
    Silverstein, MN
    Tefferi, A
    SEMINARS IN HEMATOLOGY, 1999, 36 (01) : 23 - 25
  • [4] Anagrelide in essential thrombocythemia (ET)
    Peraino, M
    Bizzoni, L
    Bernasconi, S
    Spadea, A
    Russo, D
    Cervellera, M
    Mazzucconi, MG
    THROMBOSIS RESEARCH, 1998, 91 (03) : S25 - S26
  • [5] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA WITH ANAGRELIDE
    CHINTAGUMPALA, MM
    KENNEDY, LL
    STEUBER, CP
    JOURNAL OF PEDIATRICS, 1995, 127 (03): : 495 - 498
  • [6] Anagrelide hydrochloride for essential thrombocythemia
    Besses, Carles
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (12): : 1049 - 1062
  • [7] ESSENTIAL THROMBOCYTHEMIA IN A CHILD - MANAGEMENT WITH ANAGRELIDE
    CHINTAGUMPALA, MM
    STEUBER, CP
    MAHONEY, DH
    OGDEN, AK
    FERNBACH, DJ
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1991, 13 (01): : 52 - 56
  • [8] Successful treatment of essential thrombocythemia with anagrelide in a child
    Hermann, J
    Fuchs, D
    Sauerbrey, A
    Hempel, L
    Zintl, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 30 (06): : 367 - 370
  • [9] Efficacy and safety of anagrelide in childhood essential thrombocythemia
    Kanai, Ayako
    Morokawa, Hirokazu
    Matsuda, Kazuyuki
    Shimazaki, Ei
    Nakazawa, Yozo
    PEDIATRICS INTERNATIONAL, 2017, 59 (09) : 1017 - 1018
  • [10] Thrombotic risk correlates with mutational status in true essential thrombocythemia
    Bertozzi, Irene
    Peroni, Edoardo
    Coltro, Giacomo
    Bogoni, Giulia
    Cosi, Elisabetta
    Santarossa, Claudia
    Fabris, Fabrizio
    Randi, Maria L.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (08) : 683 - 689
12345